Company insiders operate in a very predictable fashion. Defined as officers, directors and outside shareholders who control more than 5% of company stock, these insiders tend to sell company shares when… Read More

From its 2009 lows near $3 a share, Bank of America (NYSE: BAC) made a massive rebound near the $20 level in 2009 and 2010, but then saw a renewed push down with last year’s base lows at $7. The move back above the $10 pivot point this year sets… Read More

In recent decades, the airline industry repeatedly burned investors as economic slowdowns or fuel price spikes wiped out industry profits. Many investors, including Warren Buffett, have suggested that it is best to steer clear of this boom-and-bust industry.#-ad_banner-# Yet in recent years, the entire… Read More

Americans still have a healthy obsession with cars. That was on display last week, with February car sales beating the most optimistic projections for the second month in a row, while rising to their best level in more than four years. According to research firm Autodata,… Read More

Who gets your vote for most momentous fallen angel? No, not the fallen angel whose image scared the heck out of many of us in Sunday school. I’m referring to so-called “fallen angel” stocks… Read More

In recent months, Apple’s (Nasdaq: AAPL) CEO Tim Cook has repeatedly stressed that the company still has a number of aces up its sleeve. Cook has dropped coy hints that bold new products are in the pipeline, so Apple could still surprise investors… Read More

Sometimes trading the equity markets can be tricky, and even counterintuitive. Other times, it’s just a simple matter of buying the trend and then watching your money grow. The latter circumstance has been the case of late… Read More

If you want to be a thorough investor, then it’s absolutely crucial to keep track of once-loved growth stocks that have fallen out of favor. Many investors simply move on to other ideas, not fully understanding that lagging growth stocks may simply be suffering… Read More

As most investors are probably aware, headlines and mispricings often uncover short-term profit opportunities with stocks. I actually talked about this last month, when I compared the fundamentals and… Read More

Generic drug companies are standing on the cusp of a once-in-a-lifetime opportunity.#-ad_banner-# In the next five years, a total of $290 billion in prescription drug sales are expected to lose patent protection, making brand-name pharmaceutical companies vulnerable to generic competition. The… Read More